The current AKER market cap is 97.49M. The company's latest EPS is USD -0.3850 and P/E is -6.10.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.71M | -3.81M | -2.59M | -5.78M | -3.84M |
Net Income | -3.69M | -3.75M | -1.67M | -4.01M | 2.35M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.67M | 1.58M | 0 | 0 | 0 |
Operating Income | -10.78M | -3.98M | -12.29M | -28.2M | -15.28M |
Net Income | -10.85M | -3.89M | -17.58M | -29.89M | -15.2M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 20.23M | 17.54M | 28.41M | 25.25M | 21.83M |
Total Liabilities | 1.9M | 2.85M | 14.4M | 13.75M | 5.72M |
Total Equity | 18.33M | 14.7M | 13.09M | 10.74M | 15.5M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.81M | 10.89M | 36.84M | 24.81M | 17.54M |
Total Liabilities | 1.97M | 1.53M | 2.26M | 1.17M | 2.85M |
Total Equity | 5.83M | 9.36M | 34.58M | 23.65M | 14.7M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.02M | -12.27M | -3.97M | -7.89M | -11.05M |
Investing | 4.23M | 6.91M | -11.28M | -7.45M | -4.09M |
Financing | 5.55M | 5.55M | 14.69M | 14.69M | 14.69M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.52M | -3.07M | -11.93M | -19.52M | -12.27M |
Investing | -344k | -3.94M | -8.76M | 19.85M | 6.91M |
Financing | 9.11M | 6.97M | 38.67M | 74k | 5.55M |
Market Cap | 97.49M |
Price to Earnings Ratio | -6.10 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 123.68 |
Price to Book Ratio | 6.31 |
Dividend Yield | - |
Shares Outstanding | 39.47M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.09 (3.6%) |
Company Name | Akers Biosciences Inc |
Address |
855 n. wolfe street baltimore, maryland 21205 |
Website | https://www.mymd.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.